134 related articles for article (PubMed ID: 10908682)
1. Neuroprotective potential of a viral vector system induced by a neurological insult.
Ozawa CR; Ho JJ; Tsai DJ; Ho DY; Sapolsky RM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9270-5. PubMed ID: 10908682
[TBL] [Abstract][Full Text] [Related]
2. Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults.
Ho DY; Saydam TC; Fink SL; Lawrence MS; Sapolsky RM
J Neurochem; 1995 Aug; 65(2):842-50. PubMed ID: 7616244
[TBL] [Abstract][Full Text] [Related]
3. Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system.
Ho DY; McLaughlin JR; Sapolsky RM
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):200-9. PubMed ID: 8883953
[TBL] [Abstract][Full Text] [Related]
4. A herpes simplex virus vector overexpressing the glucose transporter gene protects the rat dentate gyrus from an antimetabolite toxin.
Dash R; Lawrence M; Ho D; Sapolsky R
Exp Neurol; 1996 Jan; 137(1):43-8. PubMed ID: 8566211
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 27 delivered via a herpes simplex virus vector can protect neurons of the hippocampus against kainic-acid-induced cell loss.
Kalwy SA; Akbar MT; Coffin RS; de Belleroche J; Latchman DS
Brain Res Mol Brain Res; 2003 Mar; 111(1-2):91-103. PubMed ID: 12654509
[TBL] [Abstract][Full Text] [Related]
6. Limitations in the neuroprotective potential of gene therapy with Bcl-2.
Phillips RG; Lawrence MS; Ho DY; Sapolsky RM
Brain Res; 2000 Mar; 859(2):202-6. PubMed ID: 10719065
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss.
Lawrence MS; Ho DY; Dash R; Sapolsky RM
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7247-51. PubMed ID: 7638175
[TBL] [Abstract][Full Text] [Related]
8. An adenoviral vector expressing the glucose transporter protects cultured striatal neurons from 3-nitropropionic acid.
Fink SL; Ho DY; McLaughlin J; Sapolsky RM
Brain Res; 2000 Mar; 859(1):21-5. PubMed ID: 10720611
[TBL] [Abstract][Full Text] [Related]
9. Defective herpes simplex virus vectors expressing the rat brain stress-inducible heat shock protein 72 protect cultured neurons from severe heat shock.
Fink SL; Chang LK; Ho DY; Sapolsky RM
J Neurochem; 1997 Mar; 68(3):961-9. PubMed ID: 9048741
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection with herpes simplex vectors expressing virally derived anti-apoptotic agents.
Roy M; Hom J; Sapolsky RM
Brain Res; 2001 May; 901(1-2):12-22. PubMed ID: 11368945
[TBL] [Abstract][Full Text] [Related]
11. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene.
Ho DY; Mocarski ES; Sapolsky RM
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3655-9. PubMed ID: 8386379
[TBL] [Abstract][Full Text] [Related]
12. HSV-mediated delivery of virally derived anti-apoptotic genes protects the rat hippocampus from damage following excitotoxicity, but not metabolic disruption.
Roy M; Hom JJ; Sapolsky RM
Gene Ther; 2002 Feb; 9(3):214-9. PubMed ID: 11859425
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer with herpes simplex vectors.
Lachmann RH; Efstathiou S
Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
[TBL] [Abstract][Full Text] [Related]
14. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
15. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke.
Lawrence MS; McLaughlin JR; Sun GH; Ho DY; McIntosh L; Kunis DM; Sapolsky RM; Steinberg GK
J Cereb Blood Flow Metab; 1997 Jul; 17(7):740-4. PubMed ID: 9270490
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo.
Lawrence MS; Ho DY; Sun GH; Steinberg GK; Sapolsky RM
J Neurosci; 1996 Jan; 16(2):486-96. PubMed ID: 8551333
[TBL] [Abstract][Full Text] [Related]
19. Defective viral vectors as agents for gene transfer in the nervous system.
Kaplitt MG; Makimura H
J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy.
Yenari MA; Fink SL; Sun GH; Chang LK; Patel MK; Kunis DM; Onley D; Ho DY; Sapolsky RM; Steinberg GK
Ann Neurol; 1998 Oct; 44(4):584-91. PubMed ID: 9778256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
